N-Acetyl Selank

£29.99

  • UK Stock
  • Secure Payments
  • Discreet UK Delivery

N-Acetyl Selank is an acetylated Selank derivative supplied as lyophilised research material. Compound references, batch documentation and linked literature are provided below. Not for human or veterinary use.

COMPLETE YOUR KIT

Bacteriostatic Water - 3ml
Bacteriostatic Water - 3ml

In stock

£3.99
N-Acetyl Semax - 10mg
N-Acetyl Semax - 10mg

In stock

£29.99
1 Vial
£29.99
1 Vial
£26.99 Save 10%
3 Vials
£25.49 Save 15%
5 Vials
£23.99 Save 20%

For in vitro laboratory research only.
Not for human or veterinary use. Not for diagnosis, treatment, cure, or prevention of any disease. No dosage, administration, or injection guidance is provided.

This product is currently sold out!

No worries! Please enter your e-mail address and we will promptly notify you as soon as the item is back in stock.

Great! You have been added to the waitlist for this product. Please check your inbox and confirm the subscription to this waitlist.

N-Acetyl Selank is an N-terminally acetylated derivative of the seven-residue Selank peptide, supplied as a lyophilised research material. It is distinct from unmodified Selank and N-Acetyl Selank Amidate.

Research material only
This material is not supplied as a medicine, treatment, supplement or consumer product. It is not for human or veterinary use, consumption or administration, and is not intended to diagnose, treat, cure or prevent any disease.

Compound overview

Compound classN-acetylated synthetic heptapeptide
Reference sequenceAc-Thr-Lys-Pro-Arg-Pro-Gly-Pro-OH
Reference molecular formulaC₃₅H₅₉N₁₁O₁₀
Reference monoisotopic mass793.4446 Da
Terminal modificationN-terminal acetylation; free-acid reference form
Supplied formLyophilised research material

Research context

Ac denotes the N-terminal acetyl group. The reference sequence, formula and monoisotopic mass above describe the non-amidated molecule characterised by Vanhee et al. N-Acetyl Selank Amidate has a different C-terminal group and is a distinct chemical entity. Verify terminal chemistry against the applicable batch documentation; a product name alone is not structural confirmation.

Published parent-Selank research includes rat experiments examining neurotransmission-related gene expression and hippocampal BDNF expression. These studies do not establish that N-Acetyl Selank has the same biological effects. The linked analytical study provides identification context, not evidence of cognitive enhancement or human safety. See the Research tab for study-specific notes.

Reference values do not establish batch identity, purity or suitability. Counterions, water content and formulation can affect measurements. Monoisotopic mass is not the same quantity as average molecular weight.

Batch documentation

Independent analytical documentation is published where available for specific batches and variations. Match the compound, terminal form, vial size and batch identifier to the corresponding report before relying on any result. No published result indicator means no product-specific result is currently displayed for that variation.

Supply and laboratory handling

  • Supplied in the vial size selected above.
  • Provided as a lyophilised research material.
  • Keep the vial sealed and protected from moisture, heat and direct light.
  • Use suitable laboratory controls and independently verify identity and concentration for the intended experimental model.

Frequently asked questions

What is N-Acetyl Selank?

An acetylated derivative of Selank, supplied for laboratory research. NA Selank is shorthand for N-Acetyl Selank.

Is it the same as Selank or N-Acetyl Selank Amidate?

No. N-terminal acetylation and C-terminal amidation are separate modifications. Use documentation specific to the selected chemical form.

What does the reference mass describe?

The monoisotopic mass of the non-amidated reference molecule reported in the analytical literature, not a measured result for this batch.

Do parent-Selank papers prove effects for this product?

No. Results for unmodified Selank cannot automatically be assigned to its acetylated derivative. The Research tab identifies which material each paper concerns.

Are laboratory results available?

Check the COA tab for available records and match the product variation and batch identifier before relying on a report.

How should the material be stored?

See the Storage Guidelines tab and follow any batch-specific instructions. No human dosing, administration or injection guidance is provided.

Information reviewed 27 September 2026. Reference identification source: Vanhee et al., Drug Testing and Analysis, 2020, Table 1.

Size

10mg

Batch-specific analytical documentation

Independent analytical results are published for selected Havoc Labs products, vial sizes and batches. The result attached to one variation must not be treated as evidence for a different size or batch.

  • Result available: a published report is available for the marked variation.
  • Test pending: a sample has been submitted, but no completed result is being claimed.
  • No indicator: no product-specific result is currently displayed for that variation.

Check the identifiers

Always match the compound, vial size and batch reference on the product to the corresponding laboratory record. Where the laboratory provides an independent verification facility, use it to confirm the report.

Browse published lab results →

Storage and stability

Storage requirements can vary by compound, physical form, intended storage duration and batch. Follow the lot-specific documentation and your laboratory’s validated procedure wherever these are available.

Form Suggested storage Important note
Sealed lyophilised material Keep in a cool, dry place, refrigerated at 2–8°C or frozen, as appropriate for the compound and intended storage period. Keep sealed, dry and protected from direct light. Follow compound- and batch-specific documentation and avoid repeated temperature cycling.
Reconstituted solution Refrigerate at 2–8°C unless the applicable laboratory protocol specifies otherwise. Stability depends on the preparation conditions, solvent, concentration, container and handling. No universal storage period is claimed.

No universal shelf-life is claimed

Do not assume a fixed expiry or prepared-solution storage period unless it is supported by relevant stability data or batch documentation. Where a lot-specific document gives different instructions, that document takes precedence.

Published research

The analytical reference below includes N-Acetyl Selank. The biological papers concern unmodified Selank and are included only as parent-compound context. They do not establish equivalent effects, improved stability, bioavailability or human safety for the acetylated derivative.

  1. Vanhee C et al. Putative cognitive-enhancing research peptides in seized pharmaceutical preparations: analytical identification and screening. Drug Testing and Analysis, 2020;12:371–381. LC–MS/MS method-development research, with Table 1 distinguishing N-Acetyl Selank from Selank and N-Acetyl Selank Amidate. Provides reference sequence, formula and monoisotopic mass for the acetylated free-acid form. An analytical study, not a pharmacology or clinical efficacy trial. DOI: 10.1002/dta.2717. View on PubMed ↗ · Read full paper ↗
  2. Volkova A et al. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Frontiers in Pharmacology, 2016;7:31. Rat frontal-cortex study of neurotransmission-related gene expression after parent Selank or GABA exposure. Found overlapping changes in some gene-expression responses. Does not test N-Acetyl Selank, establish a single receptor mechanism or demonstrate clinical benefit. DOI: 10.3389/fphar.2016.00031. View on PubMed ↗
  3. Inozemtseva LS et al. Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo. Doklady Biological Sciences, 2008;421:241–243. Animal research examining hippocampal BDNF expression with parent Selank. Included as pathway context, not direct evidence for N-Acetyl Selank or a clinical cognitive outcome. PubMed provides no abstract for this record. DOI: 10.1134/S0012496608040066. View on PubMed ↗

Literature is not batch evidence

The cited papers concern defined experimental materials and conditions. They do not establish the identity, purity, performance or suitability of a Havoc Labs batch. Match the terminal modifications, reference structure and batch identifier against the applicable analytical documentation.

References reviewed 27 September 2026.